What to review
Research material, active ingredient and authorized medicine are distinct categories. Research-use labeling does not replace the requirements applicable to acquisition, import, handling or use.
Prepare your inquiry
Include the product or sequence, configuration, quantity, destination and required documents. The team can then review the scope and confirm the available information.
Sources and verification scope
Anvisa orienta sobre importação de insumos para canetas de GLP-1 ↗
ANVISA
Source details (original language)
- Scope
- Historical guidance on GLP-1 active ingredients
- Document section
- Identification and commercial import sections
- Limitations
- Must be read with later updates; does not establish eligibility of RUO catalog products.
- Claim verification date
- 2026-09-09
Novas medidas sobre importação e manipulação de GLP-1 ↗
ANVISA
Source details (original language)
- Scope
- Announcement of inspection and review measures
- Document section
- Inspection and proposed regulatory review measures
- Limitations
- Announcement is not a blanket authorization or a complete consolidated legal rule.
- Claim verification date
- 2026-09-09
Importing Biological Materials into the United States ↗
U.S. Customs and Border Protection
Source details (original language)
- Scope
- US import requirements depend on material and applicable agencies
- Document section
- Agency requirements and scope
- Limitations
- Research use does not automatically remove applicable requirements; no universal catalog admission claim.
- Claim verification date
- 2026-09-09
FDA approves new medication for chronic weight management ↗
FDA
Source details (original language)
- Scope
- US approval of Zepbound (tirzepatide) for the stated adult indication
- Document section
- Zepbound approval announcement
- Limitations
- Approval applies to that medicinal product and jurisdiction, not research vials.
- Claim verification date
- 2026-09-09